Search

everythinglearnresearchcommunity

for

Search:↓

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Four natural compounds were found to promote hair growth effectively.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

XMU-MP-1 stops cell growth in a human mini-organ and reduces the effectiveness of the chemotherapy drug paclitaxel.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Early physiotherapy with exercises and stretching is crucial for treating congenital torticollis.

VSELs may hold the key to longer life through regenerative therapies.

Probiotics with Lactobacillus reuteri improve IBS symptoms in children.

Low dose methotrexate does not increase hair fall and may reduce it.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Some alopecia treatments might help treat COVID-19, but more research is needed.

Puerariae Lobatae Radix can reduce sebaceous gland size and secretion, potentially treating related skin conditions.